Finance

Lists
Why is 190A down 5.80%?
Dive Deeper
190A:TYO
Chordia Therapeutics Inc
¥65.00
-5.80%
(-4.00) 1D
Oct 1, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 190A...
Open
¥69
High
¥69
Low
¥64
Mkt. cap
5.02B
Avg. vol.
519.08K
Volume
1.86M
52-wk high
¥179
52-wk low
¥64
EPS
-¥20
No. of employees
20
Open
¥69
High
¥69
Low
¥64
Mkt. cap
5.02B
Avg. vol.
519.08K
Volume
1.86M
52-wk high
¥179
52-wk low
¥64
EPS
-¥20
No. of employees
20
News stories
From web sources and news partners
About Chordia Therapeutics Inc
CEO-
Employees20
FoundedOct 12, 2017
Headquarters-
SectorBiotechnology
Websitechordiatherapeutics.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
299.45M
229.68M
280.65M
331.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.46M
76.58M
75.81M
76.81M
Operating expense
368.90M
306.26M
356.47M
407.97M
Total operating expenses
368.90M
306.26M
356.47M
407.97M
Operating income
-368.90M
-306.26M
-356.47M
-407.97M
Other non operating income
-13.68M
16.43M
18.16M
-2.17M
EBT including unusual items
-385.91M
-294.85M
-337.91M
-413.51M
EBT excluding unusual items
-385.91M
-294.85M
-337.91M
-413.51M
Income tax expense
605.00K
475.00K
475.00K
475.00K
Effective tax rate
-0.16%
-0.16%
-0.14%
-0.11%
Other operating expenses
-
-
-
-
Net income
-386.52M
-295.32M
-338.38M
-413.98M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-368.23M
-305.58M
-355.79M
-407.29M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps